Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Receivables - Other: 2021-2024

Historic Receivables - Other for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Dec 2024 value amounting to $892.28.

  • ProQR Therapeutics N.V's Receivables - Other rose 102.81% to $1,715 in Q3 2025 from the same period last year, while for Sep 2025 it was $1,715, marking a year-over-year increase of 102.81%. This contributed to the annual value of $892.28 for FY2024, which is 10.72% up from last year.
  • As of FY2024, ProQR Therapeutics N.V's Receivables - Other stood at $892.28, which was up 10.72% from $805.88 recorded in FY2023.
  • Over the past 5 years, ProQR Therapeutics N.V's Receivables - Other peaked at $317,150 during FY2021, and registered a low of $382.59 during FY2022.
  • In the last 3 years, ProQR Therapeutics N.V's Receivables - Other had a median value of $805.88 in 2023 and averaged $693.58.
  • As far as peak fluctuations go, ProQR Therapeutics N.V's Receivables - Other tumbled by 99.88% in 2022, and later soared by 110.64% in 2023.
  • ProQR Therapeutics N.V's Receivables - Other (Yearly) stood at $317,150 in 2021, then slumped by 99.88% to $382.59 in 2022, then skyrocketed by 110.64% to $805.88 in 2023, then increased by 10.72% to $892.28 in 2024.